These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 23098499)
1. CD4+, IL17 and Foxp3 expression in different pTNM stages of operable non-small cell lung cancer and effects on disease prognosis. Zhang GQ; Han F; Fang XZ; Ma XM Asian Pac J Cancer Prev; 2012; 13(8):3955-60. PubMed ID: 23098499 [TBL] [Abstract][Full Text] [Related]
2. [Expression of CD4(+) and IL-17, Foxp3 in non-small cell lung cancer and their correlation with microvessel density]. Zhang GQ; Han F; Fang XZ; Ma XM Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):596-9. PubMed ID: 23158993 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of TAZ expression in resected non-small cell lung cancer. Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233 [TBL] [Abstract][Full Text] [Related]
4. High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients. Wei LX; Zhou RS; Xu HF; Wang JY; Yuan MH Tumour Biol; 2013 Apr; 34(2):941-6. PubMed ID: 23264086 [TBL] [Abstract][Full Text] [Related]
5. High TBX2 expression predicts poor prognosis in non-small cell lung cancer. Zhang Z; Guo Y Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744 [TBL] [Abstract][Full Text] [Related]
6. [Expression of alpha-tubulin and MDR1 and their correlation with the biological features of non-small cell lung carcinoma]. Chen QY; Jiang ZY; Wu LJ; Zhang BY; Lu GH; Zhou JY Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):278-82. PubMed ID: 20510079 [TBL] [Abstract][Full Text] [Related]
7. Expression and significance of hypoxia inducible factor-1α and lysyl oxidase in non-small cell lung cancer. Ping W; Jiang WY; Chen WS; Sun W; Fu XN Asian Pac J Cancer Prev; 2013; 14(6):3613-8. PubMed ID: 23886154 [TBL] [Abstract][Full Text] [Related]
8. Vasohibin-1 expression detected by immunohistochemistry correlates with prognosis in non-small cell lung cancer. Zhang T; Yu TT; Zhang DM; Hou XM; Liu XJ; Zhao D; Shan L Med Oncol; 2014 May; 31(5):963. PubMed ID: 24748406 [TBL] [Abstract][Full Text] [Related]
9. Association of FOXP3 expression with non-small cell lung cancer. Dimitrakopoulos FI; Papadaki H; Antonacopoulou AG; Kottorou A; Gotsis AD; Scopa C; Kalofonos HP; Mouzaki A Anticancer Res; 2011 May; 31(5):1677-83. PubMed ID: 21617226 [TBL] [Abstract][Full Text] [Related]
10. GOLPH3 high expression predicts poor prognosis in patients with resected non-small cell lung cancer: an immunohistochemical analysis. Zhang Y; Ma M; Han B Tumour Biol; 2014 Nov; 35(11):10833-9. PubMed ID: 25081375 [TBL] [Abstract][Full Text] [Related]
11. CXCR4 overexpression is associated with poor outcome in females diagnosed with stage IV non-small cell lung cancer. Otsuka S; Klimowicz AC; Kopciuk K; Petrillo SK; Konno M; Hao D; Muzik H; Stolte E; Boland W; Morris D; Magliocco AM; Bebb DG J Thorac Oncol; 2011 Jul; 6(7):1169-78. PubMed ID: 21623238 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of MAC30 is associated with poor clinical outcome in human non-small-cell lung cancer. Han KY; Gu X; Wang HR; Liu D; Lv FZ; Li JN Tumour Biol; 2013 Apr; 34(2):821-5. PubMed ID: 23229099 [TBL] [Abstract][Full Text] [Related]
13. High p-Smad2 expression in stromal fibroblasts predicts poor survival in patients with clinical stage I to IIIA non-small cell lung cancer. Chen Y; Xing P; Chen Y; Zou L; Zhang Y; Li F; Lu X World J Surg Oncol; 2014 Nov; 12():328. PubMed ID: 25373709 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of RUNX2 expression in patients with nonsmall cell lung cancer: a 5-year follow-up study. Li H; Zhou RJ; Zhang GQ; Xu JP Tumour Biol; 2013 Jun; 34(3):1807-12. PubMed ID: 23471668 [TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer. Shimizu K; Nakata M; Hirami Y; Yukawa T; Maeda A; Tanemoto K J Thorac Oncol; 2010 May; 5(5):585-90. PubMed ID: 20234320 [TBL] [Abstract][Full Text] [Related]
16. HSPA2 is expressed in human tumors and correlates with clinical features in non-small cell lung carcinoma patients. Scieglinska D; Gogler-Piglowska A; Butkiewicz D; Chekan M; Malusecka E; Harasim J; Habryka A; Krawczyk Z Anticancer Res; 2014 Jun; 34(6):2833-40. PubMed ID: 24922646 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of SH2B1 adaptor protein expression in non-small cell lung cancer. Zhang H; Duan CJ; Chen W; Wang SQ; Zhang SK; Dong S; Cheng YD; Zhang CF Asian Pac J Cancer Prev; 2012; 13(5):2355-62. PubMed ID: 22901222 [TBL] [Abstract][Full Text] [Related]
18. PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups. Schmidt LH; Kümmel A; Görlich D; Mohr M; Bröckling S; Mikesch JH; Grünewald I; Marra A; Schultheis AM; Wardelmann E; Müller-Tidow C; Spieker T; Schliemann C; Berdel WE; Wiewrodt R; Hartmann W PLoS One; 2015; 10(8):e0136023. PubMed ID: 26313362 [TBL] [Abstract][Full Text] [Related]
19. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer. Le H; Zeng F; Xu L; Liu X; Huang Y Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC). Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]